As the world is currently swept up in the global pandemic that is the coronavirus, with immunocompromised people such as cancer patients are placed at great risk. However, there is one symptom of COVID19 that may also be a warning sign of kidney cancer.
Express reports that one of the big symptoms of coronavirus may also be associated with kidney cancer, and that is suffering from a high fever or high temperature. Kidney cancer or renal cancer, is one of the most common types of cancer in the United Kingdom, and according to Cancer Research UK, the cause of certain cancers causing fevers remains to be a mystery, but it is believed that some kinds of cancer produce toxins that result in the patient suffering from a high fever.
The organization also notes that the fever does not come and stay but rather fevers caused by cancer come in cycles. For instance, the fever will come at a certain time every day, or there would be days and weeks where there is no fever and then it would happen again.
However, symptoms may overlap, and thus a high fever can be mistaken for either coronavirus or kidney cancer or even some other condition. Therefore it is best to observe and consult a doctor to get a proper diagnosis as you will have to undergo tests to identify which condition could be causing the fever. In the case of coronavirus, it is highly advised to treat the symptoms and go under self-isolation or self-quarantine until the symptoms are better and so as not to spread the pathogen onto others. Frequent hand washing and disinfecting of items that are regularly handled is also highly advised.
Meanwhile, the search for a cure to cancer continues and there have been some breakthroughs. A previous report reveals one such breakthrough made in the quest to develop a cure. A study made by researchers from National Interest found that treating the healthy cells near the cancer cells with a drug known as small molecule inhibitors improved the effects of a range of chemotherapies, as some cancers may only be treated through chemotherapy.
In one experiment pairing the drug with chemotherapy, the researchers found that the chances of survival were 90 percent longer than just using chemotherapy. This means that the cancer cells that would resist the treatment could now be removed from the body.


Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition
Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand
Trump Hints at Major Autism Announcement, Raises Questions on Tylenol Link
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
FDA Pilot Program Eases Rules for Nicotine Pouch Makers
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market
Major Drugmakers Slash U.S. Prices and Sell Directly to Patients Amid Trump’s Push for Affordable Medicines
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown
CDC Shake-Up Sparks Vaccine Policy Clash Between RFK Jr. and Susan Monarez
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China 



